(Q44855815)

6 December 2017

title

Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial (English)

1 reference

6 December 2017

1 reference

1 reference

1 reference

Char DH

1

1 reference

6 December 2017

Quivey JM

2

1 reference

6 December 2017

Castro JR

3

1 reference

6 December 2017

Kroll S

4

1 reference

6 December 2017

Phillips T

5

1 reference

6 December 2017

publication date

1 October 1993

1 reference

6 December 2017

1 reference

6 December 2017

volume

100

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

1547-1554

1 reference

Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

CHOROIDAL SARCOMA TREATED BY THE INTRAOCULAR INSERTION OF RADON SEEDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Ocular complications after therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Complications of cobalt plaque therapy of choroidal malanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Visual results following cobalt plaque radiotherapy for posterior uveal melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

The treatment of primary intraocular malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Ocular melanoma: total dose and dose rate effects with Co-60 plaque therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Progress in the use of iodine therapy for tumours of the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Choroidal melanoma: I-125 plaque therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Choroidal melanoma treatment with iodine 125 brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Changes in height of choroidal melanomas after plaque therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Five-year follow-up of helium ion therapy for uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Intraocular recurrence of uveal melanoma after proton beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Diagnostic modalities in choroidal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Planning proton therapy of the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Computer assisted treatment planning for 125I ophthalmic plaque radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

DNA cell cycle studies in uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Management of posterior uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Ciliochoroidal melanomas treated with a narrow medical proton beam

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Episcleral radioactive plaque therapy: initial clinical experience with 56 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Film dosimetry analyses on the effect of gold shielding for iodine-125 eye plaque therapy for choroidal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

The range of high LET effects from 125I decays

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Which RBE for iodine 125 in clinical applications?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

A fundamental accuracy limitation on measurements of brachytherapy sources

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Impact of Local Tumor Relapse on Patient Survival after Cobalt 60 Plaque Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

Ocular deviation after retinal detachment surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931446-6

7 January 2021

10.1016/S0161-6420(93)31446-6

Identifiers

DOI

1 reference

6 December 2017

1 reference